Navigation Links
MicroRNA regulation of tumor-killing viruses avoids unwanted viral pathology
Date:5/21/2009

Scientists have determined how to produce replication-competent viruses with key toxicities removed, providing a new platform for development of improved cancer treatments and better vaccines for a broad range of viral diseases.

Cellular microRNA molecules regulate the stability of mRNA in different cell types, and this newly-understood mechanism provides the possibility to engineer viruses for cell-specific inactivation. Cancer Research UK scientists at the University of Oxford, United Kingdom, with support from colleagues at Vrije Universiteit, Amsterdam, report that this approach can be used to regulate proliferation of adenovirus in a study published May 22 in the open-access journal PLoS Pathogens.

Adenovirus is a DNA virus widely used in cancer therapy but which causes hepatic disease in mice. Professor Len Seymour and colleagues found that introducing sites into the virus genome that are recognized by microRNA 122 leads to hepatic degradation of important viral mRNA, thereby diminishing the virus' ability to adversely affect the liver, while maintaining its ability to replicate in and kill tumor cells.

Tumor-killing replicating viruses are a hot topic in the biotherapeutics arena, with many clinical trials ongoing worldwide. That Professor Seymour's group set out to and has now defined a mechanism whereby wild type virus potency could be maintained in tumor cells but the virus could be 'turned off' in tissues vulnerable to pathology adds important information to the current base of knowledge.

"This approach is surprisingly effective and quite versatile. It could find a range of applications in controlling the activity of therapeutic viruses, both for cancer research and also to engineer a new generation of conditionally-replicating vaccines, where the vaccine pathogen is disabled in its primary sites of toxicity," Professor Seymour says.

The present study was intended mainly to explore and demonst
'/>"/>

Contact: Emma Gilgunn-Jones
emma.gilgunn-jones@cancer.org.uk
44-207-061-8311
Public Library of Science
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Exiqon Announces New Grant Program for MicroRNA Research
2. Throwing the micro switch: MicroRNA may link smoking risk gene to neurobiology of addiction
3. InteRNA Technologies and Radboud University Nijmegen Medical Centre to Develop microRNA-based Therapeutics for Prostate Cancer
4. MicroRNA undermines tumor suppression
5. MicroRNAs make for safer cancer treatments
6. Gladstone scientists identify single microRNA that controls blood vessel development
7. Putting microRNAs on the stem cell map
8. Need microRNA processing? Get Smad
9. MicroRNA controls expression of oncogenes
10. MicroRNAs appear essential for retinal health
11. MicroRNAs, EMT and cancer progression

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...USNewswire/ -- Pharmaceutical Research and Manufac...n Johnson released the following statement regardi...e disappointed, but not surprised by today,s vote ... Americans as well as nearly half of the members o...nst the bill. ,, "While well intentioned, the b...
(Date:11/8/2009)...Health Care Reform Bill ,, Critical legislati... all Americans ,, BALTIMORE, Nov. 7 /PRNewswir...tes House of Representatives passed critical healt...dicare for seniors and end discrimination by insur...ut of affordable health coverage. ,, The Afford...
(Date:11/7/2009)...ewswire/ -- The American Medical Association (AMA)...at the Family Violence Prevention Fund, with the C...i-annual policy-making meeting. The Citation for ... House of Delegates bestows on a non-physician. ...h/20081209/AMALOGO ) ,, "Ms. James has worked...
(Date:11/7/2009)...ve a responsibility to vigorously oppose abortion ..., WASHINGTON, Nov. 7 /PRNewswire-USNewswire/ -...ased the following statement on the news that Card...si,s Affordable Health Care for America Act (H.R. ... quo for abortion is voted upon. ,, "Our Catho...
(Date:11/7/2009)...h will rebel, expert says , , SATURDAY, No...behave badly if their parents expect them to, a ne...y are simply being realistic might actually contri...nan, a psychology professor at Wake Forest Univers...ty news release. "Negative expectations on the par...
Breaking Medicine News(10 mins):Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors Family Violence Prevention Expert 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2
...surgery, obstetrics and gynecology will get a $15,...t to continue the work they are already doing. // ...general practitioners who carry out procedures con...program. Australian health minister Tony Abbott...
...rom McMaster University in their clinical trial re...ntiarrhythmic drugs such as amiodarone combined wi...e the painful shocks in ventricular arrhythmia pat...icular arrhythmias, but these shocks are very pain...
...ontinue to soar if steps are not taken to improve ...ing to recover after losing their third child, whi... Speaking at Talchampei village in tribal-domi...spital but it was too late." The story of 16-...
...ondon a high vegetable and low meat diet is wonder...y to have high blood pressure// The study is...ources are better for BP than meat proteins. ...n meat eaters. "Our results are consistent w...
... reported that very little precautionary measures ... illness (bird flu) // . The infection in humans i...influenza. Hence to prevent the global pandemi...vaccine or drug that could prevent the disease fro...
...ist in radioactive waste, hot springs and fecal ma...e the human stomach. // This finding could eventua...tinal diseases and newer treatment strategies. ...chanism by which the stomach could harbor such a v...
Other Medicine News:Health News:Specialist rural GPs to get incentive in Australia 2Health News:Poverty Claims Valuable Lives Of Children In Orissa 2
(Date:11/6/2009)... Facet Solutions, Inc. announced today that it has... The acquisition creates an undisputed leadership ...ty and clinical experience in posterior motion pre...rom lumbar spinal stenosis," stated Facet Solution...idation further strengthens Facet Solutions, posit...
(Date:11/6/2009)...all/ -- Boston Scientific Corporation (NYSE: BSX ... in principle with the U.S. Department of Justice ...Guidant subsidiary in 2005. The alleged conduct a...ic,s 2006 acquisition of Guidant. ,, Boston Sci...by the U.S. Attorney,s Office in Minneapolis into ...
(Date:11/6/2009)... Philips Respironics applauds the efforts of the C... raise awareness about an important public health ...lease of the first-ever government study to monito... milestone in quantifying the size and scope of th...y leader and sleep therapy manufacturer, Philips R...
Breaking Medicine Technology:Facet Solutions Acquires Archus Orthopedics 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2CardioDynamics Shareholders Approve Merger Agreement with SonoSite 54251 1CardioDynamics Shareholders Approve Merger Agreement with SonoSite 54251 2CardioDynamics Shareholders Approve Merger Agreement with SonoSite 54251 3Astellas Named Elite Winner for Employee Engagement and Commitment in Chicagos 101 Best and Brightest Companies to Work For Competition 54247 1Astellas Named Elite Winner for Employee Engagement and Commitment in Chicagos 101 Best and Brightest Companies to Work For Competition 54247 2ParagonRx Sponsors Webinar on Demand By DSEC on Role of Drug Safety Officers 13507 1
... CAMBRIDGE, Mass. and COLUMBUS, Ohio, Jan. 8 Intel...ary nucleic acid assays, today announced that veri...antitative Assay are complete. , , Under the ver...ty, specificity and reproducibility and robustness...d. The data obtain agreed with internally generate...
... FREDERICK, Md., Jan. 7 ImQuest Life Sciences ann...pplication to the Food and Drug Administration to ...midinedione HIV inhibitor IQP-0410. ImQuest antici...t quarter of 2009. IQP-0410 is a novel small molec...nucleoside reverse transcriptase inhibitor (NNRTI)...
Other Medicine Technology:Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 3ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2
Creatinine (Liquid)
Magnesium (Liquid)
Anti-Streptolysin O (ASO) Liquid
IgE
Medicine Products: